Serum-dependent processing of late apoptotic cells for enhanced efferocytosis

Cell Death and Disease

Volumn 5, Issue , 2014, Pages

  Liang, Y Y ^a   Arnold, T ^a   Michlmayr, A ^a   Rainprecht, D ^a   Perticevic, B ^a   Spittler, A ^a   Oehler, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Complement component C1q; Efferocytosis; Phagocytosis; Serum

Indexed keywords

COMPLEMENT COMPONENT C1Q; ETOPOSIDE; FLUOROURACIL; G ACTIN; IRINOTECAN; OXALIPLATIN;

APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CELL DEATH; CHROMATIN CONDENSATION; COMPLEMENT FIXATION; CYTOLOGY; DNA CONTENT; DNA DEGRADATION; EFFEROCYTOSIS; HUMAN; HUMAN CELL; MONOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; COCULTURE; JURKAT CELL LINE; METABOLISM; NECROSIS; PATHOLOGY;

APOPTOSIS; COCULTURE TECHNIQUES; COMPLEMENT C1Q; HUMANS; JURKAT CELLS; MONOCYTES; NECROSIS;

EID: 84905667841     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.210     Document Type: Article

References (30)

1. Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 2014; 14: 166-180.
2. Ortega-Gomez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med 2013; 5: 661-674.
3. Elliott MR, Ravichandran KS. Clearance of apoptotic cells: Implications in health and disease. J Cell Biol 2010; 189: 1059-1070.
4. Poon IK, Hulett MD, Parish CR. Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ 2010; 17: 381-397.
5. Peter C,Wesselborg S, Herrmann M, Lauber K. Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells. Apoptosis 2010; 15: 1007-1028.
6. Li G, Liang X, Lotze MT. HMGB1: the central cytokine for all lymphoid cells. Front Immunol 2013; 4: 68.
7. Martin M, Leffler J, Blom AM. Annexin A2 and a5 serve as new ligands for c1q on apoptotic cells. J Biol Chem 2012; 287: 33733-33744.
8. Paidassi H, Tacnet-Delorme P, Garlatti V, Darnault C, Ghebrehiwet B, Gaboriaud C et al. C1q binds phosphatidylserine and likely acts as a multiligand-bridging molecule in apoptotic cell recognition. J Immunol 2008; 180: 2329-2338.
9. Nauta AJ, Castellano G, Xu W, Woltman AM, Borrias MC, Daha MR et al. Opsonization with C1q and mannose-binding lectin targets apoptotic cells to dendritic cells. J Immunol 2004; 173: 3044-3050.
10. Fishelson Z, Attali G, Mevorach D. Complement and apoptosis. Mol Immunol 2001; 38: 207-219.
11. Mevorach D. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system. Apoptosis 2010; 15: 1114-1123.
12. Gullstrand B, Martensson U, Sturfelt G, Bengtsson AA, Truedsson L. Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 2009; 156: 303-311.
13. Taylor PR, Carugati A, Fadok VA, Cook HT, Andrews M, Carroll MC et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med 2000; 192: 359-366.
14. Erwig LP, Henson PM. Clearance of apoptotic cells by phagocytes. Cell Death Differ 2008; 15: 243-250.
15. Kang YH, Urban BC, Sim RB, Kishore U. Human complement Factor H modulates C1q-mediated phagocytosis of apoptotic cells. Immunobiology 2012; 217: 455-464.
16. Trouw LA, Bengtsson AA, Gelderman KA, Dahlback B, Sturfelt G, Blom AM. C4b-binding protein and factor H compensate for the loss of membrane-bound complement inhibitors to protect apoptotic cells against excessive complement attack. J Biol Chem 2007; 282: 28540-28548.
17. Gaipl US, Beyer TD, Heyder P, Kuenkele S, Bottcher A, Voll RE et al. Cooperation between C1q and DNase I in the clearance of necrotic cell-derived chromatin. Arthritis Rheum 2004; 50: 640-649.
18. Rosenwald M, Koppe U, Keppeler H, Sauer G, Hennel R, Ernst A et al. Serum-derived plasminogen is activated by apoptotic cells and promotes their phagocytic clearance. J Immunol 2012; 189: 5722-5728.
19. Michlmayr A, Bachleitner-Hofmann T, Baumann S, Marchetti-Deschmann M, Rech- Weichselbraun I, Burghuber C et al. Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value. Br J Cancer 2010; 103: 1201-1208.
20. Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R et al. Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer. Eur J Clin Invest 2013; 43: 286-291.
21. He B, Lu N, Zhou Z. Cellular and nuclear degradation during apoptosis. Curr Opin Cell Biol 2009; 21: 900-912.
22. Lecoeur H, Melki MT, Saidi H, Gougeon ML. Analysis of apoptotic pathways by multiparametric flow cytometry: application to HIV infection. Methods Enzymol 2008; 442: 51-82.
23. Caruso RA, Fedele F, Finocchiaro G, Arena G, Venuti A. Neutrophil-tumor cell phagocytosis (cannibalism) in human tumors: an update and literature review. Exp Oncol 2012; 34: 306-311.
24. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW et al. A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007; 131: 966-979.
25. Krajcovic M, Overholtzer M. Mechanisms of ploidy increase in human cancers: a new role for cell cannibalism. Cancer Res 2012; 72: 1596-1601.
26. Wood W, Turmaine M, Weber R, Camp V, Maki RA, McKercher SR et al. Mesenchymal cells engulf and clear apoptotic footplate cells in macrophageless PU.1 null mouse embryos. Development 2000; 127: 5245-5252.
27. Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol 2001; 166: 3231-3239.
28. Nauta AJ, Trouw LA, Daha MR, Tijsma O, Nieuwland R, Schwaeble WJ et al. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation. Eur J Immunol 2002; 32: 1726-1736.
29. Samejima K, Earnshaw WC. Trashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol 2005; 6: 677-688.
30. Zellner M, Babeluk R, Diestinger M, Pirchegger P, Skeledzic S, Oehler R. Fluorescence-based western blotting for quantitation of protein biomarkers in clinical samples. Electrophoresis 2008; 29: 3621-3627.